Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age

BACKGROUND: To evaluate the safety and efficacy of intra-arterial chemotherapy (IAC) for the primary or secondary treatment of infants diagnosed with advanced retinoblastoma before 3 months of age. METHODS: This single-center retrospective study included 39 infants (42 eyes) aged ≤3 months who were...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qiuying, Zhang, Bin, Dong, Yuhao, Mo, Xiaokai, Zhang, Lu, Xia, Jiejun, Zhang, Jing, Zhang, Shuixing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631809/
https://www.ncbi.nlm.nih.gov/pubmed/31307410
http://dx.doi.org/10.1186/s12885-019-5844-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631809/
https://www.ncbi.nlm.nih.gov/pubmed/31307410
http://dx.doi.org/10.1186/s12885-019-5844-5

Ejemplares similares